Home › Therapeutic areas › Oncology › Cutaneous Squamous Cell Carcinoma
Cutaneous Squamous Cell Carcinoma (6 companies)
Companies with an active program in Cutaneous Squamous Cell Carcinoma.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| DRTS | Alpha Tau Medical | Oncology | 1 | Phase 2 | 5 |
| BCAX | Bicara Therapeutics | Oncology | 1 | Phase 2 | 4 |
| FBIO | Fortress Biotech | DermatologyHematology+2 Rare | 1 | Approved | 12 |
| PHIO | Phio Pharmaceuticals | Oncology | 1 | Phase 1 | 4 |
| REPL | Replimune Group | Oncology | 1 | Approved | 5 |
| VIR | Vir Biotechnology | Infectious DiseaseOncology Rare | 1 | Phase 3 | 10 |
No companies match.